Shilanski & Associates Inc. Reduces Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Shilanski & Associates Inc. reduced its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 15.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 20,359 shares of the pharmacy operator’s stock after selling 3,843 shares during the quarter. Shilanski & Associates Inc.’s holdings in Walgreens Boots Alliance were worth $190,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. First Financial Corp IN raised its holdings in Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 885 shares during the last quarter. TD Private Client Wealth LLC increased its stake in Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 3,208 shares during the last quarter. Sentry Investment Management LLC purchased a new position in Walgreens Boots Alliance during the third quarter worth about $30,000. Eastern Bank acquired a new stake in Walgreens Boots Alliance in the 3rd quarter worth about $33,000. Finally, Strategic Investment Solutions Inc. IL purchased a new stake in Walgreens Boots Alliance in the 2nd quarter valued at about $34,000. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Up 1.0 %

Shares of NASDAQ WBA opened at $11.74 on Friday. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $23.76. The stock’s 50-day simple moving average is $9.73 and its 200-day simple moving average is $9.86.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business’s revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.66 EPS. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.59 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on WBA. Jefferies Financial Group cut their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, October 23rd. Bank of America lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Truist Financial upped their price objective on Walgreens Boots Alliance from $10.00 to $13.00 and gave the stock a “hold” rating in a report on Thursday, January 16th. Evercore ISI lifted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Finally, UBS Group upped their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $13.27.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.